Evidence map›Paper›PMID 36264443›Full record

ArticleObesity surgery2022

Is Robotic Revisional Bariatric Surgery Justified? An MBSAQIP Analysis.

Tristan Seton, Mark Mahan, James Dove, Hugo Villanueva, Vladan Obradovic, Alexandra Falvo, Ryan Horsley, Anthony Petrick, David M Parker

Abstract read
PubMed Publisher
In one paragraph

Article in Obesity surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tristan SetonGeisinger Community Medical Center, 1800 Mulberry St, Scranton, PA, 18510, USA.
Mark MahanGeisinger Medical Center, 100 North Academy Ave, Danville, PA, 17821, USA.
James DoveGeisinger Medical Center, 100 North Academy Ave, Danville, PA, 17821, USA.
Hugo VillanuevaGeisinger Medical Center, 100 North Academy Ave, Danville, PA, 17821, USA.
Vladan ObradovicGeisinger Medical Center, 100 North Academy Ave, Danville, PA, 17821, USA.
Alexandra FalvoGeisinger Community Medical Center, 1800 Mulberry St, Scranton, PA, 18510, USA.
Ryan HorsleyGeisinger Community Medical Center, 1800 Mulberry St, Scranton, PA, 18510, USA.
Anthony PetrickGeisinger Medical Center, 100 North Academy Ave, Danville, PA, 17821, USA.
David M ParkerGeisinger Medical Center, 100 North Academy Ave, Danville, PA, 17821, USA. dparker@geisinger.edu.ORCID 0000-0002-7722-9079

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe laparoscopic approach is utilized in greater than 90% of bariatric surgeries. With the growing prevalence of robotic-assisted surgery in bariatrics, there has been limited consensus on the superiority of either laparoscopic or robotic approaches, especially in revisional procedures (conversion from sleeve gastrectomy (SG) to Roux-en-Y gastric bypass (RYGB)).

methodsA retrospective analysis was performed of the MBSAQIP PUF database of patients who underwent conversion from SG to RYGB procedures in either laparoscopic or robotic-assisted approaches. The groups underwent 2:1 propensity matching and primary outcomes included post-conversion days until discharge (POD), conversion operation length, total and major morbidity, 30-day readmission, 30-day reoperation, 30-day reintervention, and 30-day mortality after conversion.

resultsAfter 2:1 propensity score matching, 3411 patients (2274 laparoscopic vs 1137 robotic) were included in the study. Intraoperatively, no significant difference was found in total morbidity (6.5% lap vs 5.9% robotic) or major morbidity (1.9% lap vs 1.7% robotic); however, the operative times were significantly longer robotically (126 min vs 164 min). Post-operatively, no significant differences were found in discharge day (1.8 lap vs 1.8 robotic), 30-day readmission (7.6% lap vs 8.6% robotic), reoperation rate (2.9% lap vs 3.7% robotic), additional intervention rate (2.5% lap vs 3.3% robotic), or 30-day mortality (0.1% vs 0.1%).

conclusionThere is no significant difference in perioperative or intraoperative outcomes between laparoscopic and robotic-assisted SG to RYGB conversion procedures other than a longer operative time in the robotic approach, suggesting increased efficiency with the laparoscopic approach.

Indexed as

Bariatric SurgeryGastric BypassLaparoscopyObesity, MorbidRobotic Surgical ProceduresGastrectomyHumansReoperationRetrospective StudiesTreatment OutcomeBariatric revisionsLaparoscopicMBSAQIPRoboticRoux-en-y gastric bypassSleeve gastrectomy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.